<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27124303</article-id>
<article-id pub-id-type="pmc">4849793</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0153757</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-49380</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Human Genomics</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Molecular Biology</subject>
<subj-group>
<subject>Molecular Biology Techniques</subject>
<subj-group>
<subject>Artificial Gene Amplification and Extension</subject>
<subj-group>
<subject>Polymerase Chain Reaction</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Molecular Biology Techniques</subject>
<subj-group>
<subject>Artificial Gene Amplification and Extension</subject>
<subj-group>
<subject>Polymerase Chain Reaction</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Gene Identification and Analysis</subject>
<subj-group>
<subject>Mutation Detection</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genetic Loci</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Anatomy</subject>
<subj-group>
<subject>Ocular System</subject>
<subj-group>
<subject>Ocular Anatomy</subject>
<subj-group>
<subject>Iris</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Anatomy</subject>
<subj-group>
<subject>Ocular System</subject>
<subj-group>
<subject>Ocular Anatomy</subject>
<subj-group>
<subject>Iris</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Mutation</subject>
<subj-group>
<subject>Deletion Mutation</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Ophthalmology</subject>
<subj-group>
<subject>Eye Diseases</subject>
<subj-group>
<subject>Glaucoma</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Molecular Biology</subject>
<subj-group>
<subject>Molecular Biology Techniques</subject>
<subj-group>
<subject>Mutagenesis and Gene Deletion Techniques</subject>
<subj-group>
<subject>Mutational Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Molecular Biology Techniques</subject>
<subj-group>
<subject>Mutagenesis and Gene Deletion Techniques</subject>
<subj-group>
<subject>Mutational Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Analysis of ‘<italic>PAX6</italic>-Negative’ Individuals with Aniridia or Gillespie Syndrome</article-title>
<alt-title alt-title-type="running-head">Genetic Analysis of ‘<italic>PAX6</italic>-Negative’ Individuals with Aniridia or Gillespie Syndrome</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ansari</surname>
<given-names>Morad</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rainger</surname>
<given-names>Jacqueline</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hanson</surname>
<given-names>Isabel M.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williamson</surname>
<given-names>Kathleen A.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharkey</surname>
<given-names>Freddie</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harewood</surname>
<given-names>Louise</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sandilands</surname>
<given-names>Angela</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clayton-Smith</surname>
<given-names>Jill</given-names>
</name>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dollfus</surname>
<given-names>Helene</given-names>
</name>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bitoun</surname>
<given-names>Pierre</given-names>
</name>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meire</surname>
<given-names>Francoise</given-names>
</name>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fantes</surname>
<given-names>Judy</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Franco</surname>
<given-names>Brunella</given-names>
</name>
<xref ref-type="aff" rid="aff006">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lorenz</surname>
<given-names>Birgit</given-names>
</name>
<xref ref-type="aff" rid="aff008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>David S.</given-names>
</name>
<xref ref-type="aff" rid="aff009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Fiona</given-names>
</name>
<xref ref-type="aff" rid="aff010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willoughby</surname>
<given-names>Colin E.</given-names>
</name>
<xref ref-type="aff" rid="aff011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McEntagart</surname>
<given-names>Meriel</given-names>
</name>
<xref ref-type="aff" rid="aff012">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khaw</surname>
<given-names>Peng Tee</given-names>
</name>
<xref ref-type="aff" rid="aff013">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clericuzio</surname>
<given-names>Carol</given-names>
</name>
<xref ref-type="aff" rid="aff014">
<sup>14</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Maldergem</surname>
<given-names>Lionel</given-names>
</name>
<xref ref-type="aff" rid="aff015">
<sup>15</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Denise</given-names>
</name>
<xref ref-type="aff" rid="aff016">
<sup>16</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Newbury-Ecob</surname>
<given-names>Ruth</given-names>
</name>
<xref ref-type="aff" rid="aff017">
<sup>17</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Traboulsi</surname>
<given-names>Elias I.</given-names>
</name>
<xref ref-type="aff" rid="aff018">
<sup>18</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Eduardo D.</given-names>
</name>
<xref ref-type="aff" rid="aff019">
<sup>19</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madlom</surname>
<given-names>Mukhlis M.</given-names>
</name>
<xref ref-type="aff" rid="aff020">
<sup>20</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goudie</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="aff021">
<sup>21</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fleck</surname>
<given-names>Brian W.</given-names>
</name>
<xref ref-type="aff" rid="aff022">
<sup>22</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wieczorek</surname>
<given-names>Dagmar</given-names>
</name>
<xref ref-type="aff" rid="aff023">
<sup>23</sup>
</xref>
<xref ref-type="aff" rid="aff024">
<sup>24</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kohlhase</surname>
<given-names>Juergen</given-names>
</name>
<xref ref-type="aff" rid="aff025">
<sup>25</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McTrusty</surname>
<given-names>Alice D.</given-names>
</name>
<xref ref-type="aff" rid="aff026">
<sup>26</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gardiner</surname>
<given-names>Carol</given-names>
</name>
<xref ref-type="aff" rid="aff027">
<sup>27</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yale</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="aff028">
<sup>28</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Anthony T.</given-names>
</name>
<xref ref-type="aff" rid="aff013">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Russell-Eggitt</surname>
<given-names>Isabelle</given-names>
</name>
<xref ref-type="aff" rid="aff009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Islam</surname>
<given-names>Lily</given-names>
</name>
<xref ref-type="aff" rid="aff009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lees</surname>
<given-names>Melissa</given-names>
</name>
<xref ref-type="aff" rid="aff029">
<sup>29</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beales</surname>
<given-names>Philip L.</given-names>
</name>
<xref ref-type="aff" rid="aff009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tuft</surname>
<given-names>Stephen J.</given-names>
</name>
<xref ref-type="aff" rid="aff013">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solano</surname>
<given-names>Juan B.</given-names>
</name>
<xref ref-type="aff" rid="aff030">
<sup>30</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Splitt</surname>
<given-names>Miranda</given-names>
</name>
<xref ref-type="aff" rid="aff031">
<sup>31</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hertz</surname>
<given-names>Jens Michael</given-names>
</name>
<xref ref-type="aff" rid="aff032">
<sup>32</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prescott</surname>
<given-names>Trine E.</given-names>
</name>
<xref ref-type="aff" rid="aff033">
<sup>33</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shears</surname>
<given-names>Deborah J.</given-names>
</name>
<xref ref-type="aff" rid="aff034">
<sup>34</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nischal</surname>
<given-names>Ken K.</given-names>
</name>
<xref ref-type="aff" rid="aff035">
<sup>35</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doco-Fenzy</surname>
<given-names>Martine</given-names>
</name>
<xref ref-type="aff" rid="aff036">
<sup>36</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prieur</surname>
<given-names>Fabienne</given-names>
</name>
<xref ref-type="aff" rid="aff037">
<sup>37</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Temple</surname>
<given-names>I. Karen</given-names>
</name>
<xref ref-type="aff" rid="aff038">
<sup>38</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lachlan</surname>
<given-names>Katherine L.</given-names>
</name>
<xref ref-type="aff" rid="aff039">
<sup>39</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Damante</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="aff040">
<sup>40</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrison</surname>
<given-names>Danny A.</given-names>
</name>
<xref ref-type="aff" rid="aff041">
<sup>41</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Heyningen</surname>
<given-names>Veronica</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>FitzPatrick</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label>
<addr-line>MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom</addr-line></aff>
<aff id="aff002"><label>2</label>
<addr-line>Faculty of Medical and Human Sciences, Manchester Centre for Genomic Medicine, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Manchester, United Kingdom</addr-line></aff>
<aff id="aff003"><label>3</label>
<addr-line>Service de Génétique Médicale, Hôpital de Haute-Pierre, Strasbourg, France</addr-line></aff>
<aff id="aff004"><label>4</label>
<addr-line>Medical Genetics Departments, University Hospital Jean Verdier, Bondy, France</addr-line></aff>
<aff id="aff005"><label>5</label>
<addr-line>Department of ophthalmopediatrics, Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgium</addr-line></aff>
<aff id="aff006"><label>6</label>
<addr-line>Medical Genetics, Department of Medical Translational Sciences, Federico II University, Naples, Italy</addr-line></aff>
<aff id="aff007"><label>7</label>
<addr-line>Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy</addr-line></aff>
<aff id="aff008"><label>8</label>
<addr-line>Department of Ophthalmology, Justus-Liebig-University Giessen, Universitaetsklinikum Giessen and Marburg UKGM, Giessen, Germany</addr-line></aff>
<aff id="aff009"><label>9</label>
<addr-line>Institute of Child Health, University College London, UK and Great Ormond Street Hospital for Children, London, United Kingdom</addr-line></aff>
<aff id="aff010"><label>10</label>
<addr-line>Northern Ireland Regional Genetics Service (NIRGS), Belfast City Hospital, Belfast, United Kingdom</addr-line></aff>
<aff id="aff011"><label>11</label>
<addr-line>Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom</addr-line></aff>
<aff id="aff012"><label>12</label>
<addr-line>Medical Genetics Unit, St George's University of London, London, United Kingdom</addr-line></aff>
<aff id="aff013"><label>13</label>
<addr-line>Moorfields Eye Hospital, London, UK and University College London, Institute of Ophthalmology, London, United Kingdom</addr-line></aff>
<aff id="aff014"><label>14</label>
<addr-line>Department of Pediatric Genetics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America</addr-line></aff>
<aff id="aff015"><label>15</label>
<addr-line>Centre de Génétique Humaine, Université de Franche-Comté, Besançon, France</addr-line></aff>
<aff id="aff016"><label>16</label>
<addr-line>Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, United Kingdom</addr-line></aff>
<aff id="aff017"><label>17</label>
<addr-line>Department of Clinical Genetics, University Hospitals, Bristol, United Kingdom</addr-line></aff>
<aff id="aff018"><label>18</label>
<addr-line>Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, United States of America</addr-line></aff>
<aff id="aff019"><label>19</label>
<addr-line>Department Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal</addr-line></aff>
<aff id="aff020"><label>20</label>
<addr-line>Children's Hospital, Doncaster Royal Infirmary, Doncaster, United Kingdom</addr-line></aff>
<aff id="aff021"><label>21</label>
<addr-line>Human Genetics Unit, University of Dundee College of Medicine, Dentistry and Nursing, Ninewells Hospital, Dundee, United Kingdom</addr-line></aff>
<aff id="aff022"><label>22</label>
<addr-line>Department of Ophthalmology, Princess Alexandra Eye Pavilion, Chalmers Street, Edinburgh, United Kingdom</addr-line></aff>
<aff id="aff023"><label>23</label>
<addr-line>Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany</addr-line></aff>
<aff id="aff024"><label>24</label>
<addr-line>Institut für Humangenetik, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany</addr-line></aff>
<aff id="aff025"><label>25</label>
<addr-line>Center for Human Genetics, Freiburg, Germany</addr-line></aff>
<aff id="aff026"><label>26</label>
<addr-line>Department of Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom</addr-line></aff>
<aff id="aff027"><label>27</label>
<addr-line>Clinical Genetics, Southern General Hospital, Glasgow, United Kingdom</addr-line></aff>
<aff id="aff028"><label>28</label>
<addr-line>Department of Paediatrics and Child Health, Ipswich Hospital, Ipswich, United Kingdom</addr-line></aff>
<aff id="aff029"><label>29</label>
<addr-line>North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street Hospital, London, United Kingdom</addr-line></aff>
<aff id="aff030"><label>30</label>
<addr-line>Ruber International Hospital, Medical Genetics Unit, Mirasierra, Madrid, Spain</addr-line></aff>
<aff id="aff031"><label>31</label>
<addr-line>Northern Genetics Service, Institute of Genetic Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom</addr-line></aff>
<aff id="aff032"><label>32</label>
<addr-line>Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark</addr-line></aff>
<aff id="aff033"><label>33</label>
<addr-line>Department of Medical Genetics, Oslo University Hospital, Oslo, Norway</addr-line></aff>
<aff id="aff034"><label>34</label>
<addr-line>Department of Clinical Genetics, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom</addr-line></aff>
<aff id="aff035"><label>35</label>
<addr-line>UPMC Eye Center, Children's Hospital of Pittsburgh of UPMC, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America</addr-line></aff>
<aff id="aff036"><label>36</label>
<addr-line>Service de génétique, HMB CHU Reims, SFR Cap Sante. EA 3801, France</addr-line></aff>
<aff id="aff037"><label>37</label>
<addr-line>CHU de Saint Etienne, Service de génétique médicale, Saint-Etienne, France</addr-line></aff>
<aff id="aff038"><label>38</label>
<addr-line>Academic Unit of Genetic Medicine, Division of Human Genetics, University of Southampton, Southampton, United Kingdom</addr-line></aff>
<aff id="aff039"><label>39</label>
<addr-line>Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom</addr-line></aff>
<aff id="aff040"><label>40</label>
<addr-line>Department of Medical and Biological Sciences, University of Udine, Udine, Italy</addr-line></aff>
<aff id="aff041"><label>41</label>
<addr-line>St. Thomas’ Hospital, Westminster Bridge Road, London, United Kingdom</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Anderson</surname>
<given-names>Michael G</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>University of Iowa, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: DRF VvH. Performed the experiments: MA JR IMH KAW F. Sharkey LH JF. Analyzed the data: MA JR IMH KAW F. Sharkey LH JF. Contributed reagents/materials/analysis tools: AS JCS HD PB FM BF BL DST F. Stewart CEW MME PTK CC LVM DW RNE EIT EDS MMM DRG BWF DW JK ADM CG CY ATM IRE LI ML PLB SJT JBS MS JMH TEP DJS KKN MDF FP IKT KLL GD DAM. Wrote the paper: DRF VvH MA JR IMH F. Sharkey AS PB.</p>
</fn>
<corresp id="cor001">* E-mail: <email>david.fitzpatrick@igmm.ed.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>4</issue>
<elocation-id>e0153757</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 Ansari et al</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Ansari et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0153757.pdf"></self-uri>
<abstract>
<p>We report molecular genetic analysis of 42 affected individuals referred with a diagnosis of aniridia who previously screened as negative for intragenic <italic>PAX6</italic> mutations. Of these 42, the diagnoses were 31 individuals with aniridia and 11 individuals referred with a diagnosis of Gillespie syndrome (iris hypoplasia, ataxia and mild to moderate developmental delay). Array-based comparative genomic hybridization identified six whole gene deletions: four encompassing <italic>PAX6</italic> and two encompassing <italic>FOXC1</italic>. Six deletions with plausible <italic>cis</italic>-regulatory effects were identified: five that were 3ʹ (telomeric) to <italic>PAX6</italic> and one within a gene desert 5ʹ (telomeric) to <italic>PITX2</italic>. Sequence analysis of the <italic>FOXC1</italic> and <italic>PITX2</italic> coding regions identified two plausibly pathogenic <italic>de novo FOXC1</italic> missense mutations (p.Pro79Thr and p.Leu101Pro). No intragenic mutations were detected in <italic>PITX2</italic>. FISH mapping in an individual with Gillespie-like syndrome with an apparently balanced X;11 reciprocal translocation revealed disruption of a gene at each breakpoint: <italic>ARHGAP6</italic> on the X chromosome and <italic>PHF21A</italic> on chromosome 11. In the other individuals with Gillespie syndrome no mutations were identified in either of these genes, or in <italic>HCCS</italic> which lies close to the Xp breakpoint. Disruption of <italic>PHF21A</italic> has previously been implicated in the causation of intellectual disability (but not aniridia). Plausibly causative mutations were identified in 15 out of 42 individuals (12/32 aniridia; 3/11 Gillespie syndrome). Fourteen of these mutations presented in the known aniridia genes; <italic>PAX6</italic>, <italic>FOXC1</italic> and <italic>PITX2</italic>. The large number of individuals in the cohort with no mutation identified suggests greater locus heterogeneity may exist in both isolated and syndromic aniridia than was previously appreciated.</p>
</abstract>
<funding-group>
<funding-statement>MA, JR, KAW, FS, LH, JF, VvH, and DRF are funded via programme grants to the MRC Human Genetics Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="1"></table-count>
<page-count count="15"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files. ArrayCGH data have been deposited in the Database of Genomic Variants (accession ID estd228) and the DECIPHER database (<ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">decipher.sanger.ac.uk</ext-link>).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>All relevant data are within the paper and its Supporting Information files. ArrayCGH data have been deposited in the Database of Genomic Variants (accession ID estd228) and the DECIPHER database (<ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">decipher.sanger.ac.uk</ext-link>).</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Abnormal development of the iris is a feature of a variety of congenital human ocular anomalies, of which, the best characterized is complete aniridia (MIM 106210), a dominantly inherited condition with an incidence of less than 1 in 50,000 [<xref ref-type="bibr" rid="pone.0153757.ref001">1</xref>]. Aniridia presents as congenital absence of the iris, although a visible partial rim or sector of iris tissue strand is often present [<xref ref-type="bibr" rid="pone.0153757.ref002">2</xref>]. Foveal hypoplasia, cataract, keratopathy and glaucoma sometimes develop in second or third decade contributing to visual morbidity [<xref ref-type="bibr" rid="pone.0153757.ref003">3</xref>]. Non-ocular anomalies including hyposmia and structural brain changes are sometimes observed in individuals with complete aniridia [<xref ref-type="bibr" rid="pone.0153757.ref004">4</xref>].</p>
<p>At least 90% of aniridia cases are caused by heterozygous loss-of-function mutations in <italic>PAX6</italic> [<xref ref-type="bibr" rid="pone.0153757.ref005">5</xref>]. Almost all cases of classical aniridia associated with <italic>PAX6</italic> haploinsufficiency present with foveal hypoplasia. Heterozygous, presumed hypomorphic, missense mutations in <italic>PAX6</italic> have also been associated with other ocular diseases including anterior segment dysgenesis [<xref ref-type="bibr" rid="pone.0153757.ref006">6</xref>] and optic nerve malformations [<xref ref-type="bibr" rid="pone.0153757.ref007">7</xref>]. Rarely, isolated aniridia is caused by mutations in <italic>FOXC1</italic> [<xref ref-type="bibr" rid="pone.0153757.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0153757.ref009">9</xref>] or <italic>PITX2</italic> [<xref ref-type="bibr" rid="pone.0153757.ref010">10</xref>]. Mutations in these genes are more commonly associated with juvenile-onset glaucoma [<xref ref-type="bibr" rid="pone.0153757.ref011">11</xref>] and anterior segment dysgenesis [<xref ref-type="bibr" rid="pone.0153757.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0153757.ref014">14</xref>] presenting with syndromic features of rare cardiac anomalies for <italic>FOXC1</italic> and hypodontia and umbilical anomalies for <italic>PITX2</italic>.</p>
<p>Several syndromic forms of iris developmental anomalies have been described. The best known is WAGR (Wilms’ tumour, aniridia, genital anomalies and mental retardation; MIM 194072), a contiguous deletion syndrome on 11p13 [<xref ref-type="bibr" rid="pone.0153757.ref015">15</xref>]. Gillespie syndrome (MIM 206700) is characterized by a pathognomonic iris anomaly; absence of the pars pupillaris of the iris and the pupillary border. Individuals with Gillespie syndrome are also distinguished from complete aniridia by having a normal fovea and no evidence of progressive opacification of the cornea and lens, nor development of glaucoma. The extraocular features are non-progressive cerebellar ataxia and psychomotor delay [<xref ref-type="bibr" rid="pone.0153757.ref016">16</xref>]. Several cases of Gillespie syndrome have been reported [<xref ref-type="bibr" rid="pone.0153757.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0153757.ref039">39</xref>].</p>
<p>In the literature, Gillespie syndrome has been most commonly considered to be an autosomal recessive disorder [<xref ref-type="bibr" rid="pone.0153757.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0153757.ref038">38</xref>]. Analysis of the <italic>PAX6</italic> gene in six Gillespie syndrome patients revealed no intragenic mutations [<xref ref-type="bibr" rid="pone.0153757.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0153757.ref026">26</xref>,<xref ref-type="bibr" rid="pone.0153757.ref040">40</xref>]. <italic>PAX6</italic> mutations have been reported in two individuals [<xref ref-type="bibr" rid="pone.0153757.ref033">33</xref>,<xref ref-type="bibr" rid="pone.0153757.ref039">39</xref>] described as Gillespie syndrome but with significantly atypical features such as corectopia and ptosis (33). A single affected girl described as having a Gillespie syndrome-like phenotype has been reported with an apparently balanced X:autosome reciprocal translocation t(X;11)(p22.32;p12) [<xref ref-type="bibr" rid="pone.0153757.ref022">22</xref>] and atypical features of superior coloboma, foveal hypoplasia and vermis hypoplasia. This case is included in this study as individual 1371.</p>
<p>Here, we report genomic copy number and extended mutation analysis in 42 unrelated affected individuals all of whom had been scored as negative for intragenic <italic>PAX6</italic> mutations. Eleven of these probands had been referred to us with a diagnosis of Gillespie syndrome and 31 with non-syndromic aniridia. One of the 11 Gillespie syndrome individuals was the case with the apparently balanced reciprocal translocation t(X:11)(p22.32;p12) [<xref ref-type="bibr" rid="pone.0153757.ref022">22</xref>]. In this case we used FISH to map both breakpoints. In total, 15 plausible disease-causing heterozygous loss-of-function mutations were identified: nine affecting <italic>PAX6</italic>, four affecting <italic>FOXC1</italic>, one affecting <italic>PITX2</italic> and one affecting <italic>PHF21A</italic>. These data suggest that other disease loci or mutational mechanisms causing aniridia remain to be discovered.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec003">
<title>Patient samples</title>
<p>All aspects of this study were performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from the participants and recorded. The study was approved by the UK Multicentre Regional Ethics Committee under the number 06/MRE00/76. All patients were phenotypically characterized by experienced ophthalmologists or geneticists. The study cohort consisted of 42 unrelated individuals with aniridia or Gillespie syndrome (<xref ref-type="supplementary-material" rid="pone.0153757.s003">S1 Table</xref>) each of whom had been previously screened for intragenic <italic>PAX6</italic> mutations by single-strand conformation polymorphism (SSCP), denaturing high performance liquid chromatography (DHPLC) and direct sequencing (<xref ref-type="supplementary-material" rid="pone.0153757.s004">S2 Table</xref>).</p>
</sec>
<sec id="sec004">
<title>DNA preparation and quality control</title>
<p>Genomic DNA was prepared from either lymphoblastoid cell lines (LCL) or saliva using a Nucleon DNA extraction kit (Tepnel Life Sciences, UK). DNA quality was checked by agarose gel electrophoresis and NanoDrop spectrophotometry (Thermo Scientific).</p>
</sec>
<sec id="sec005">
<title>Array comparative genomic hybridization (aCGH)</title>
<p>Genome-wide analysis of DNA copy number was carried out using the Roche Nimblegen 12X135k whole-genome array (median probe spacing of approximately 12 kb) according to the manufacturer’s instructions with minor modifications, as described previously [<xref ref-type="bibr" rid="pone.0153757.ref041">41</xref>].</p>
<p>Targeted analysis of genomic deletions/duplications was performed using a customized oligonucleotide microarray (Agilent Technologies) consisting of 44,000 60-mer oligonucleotide probes (4X44k), designed using eArray (Agilent Technologies). The design consisted of a 3 Mb genomic region (chr11:30,262,916–33,296,085; hg18) containing the <italic>PAX6</italic> gene with an average probe spacing of 76 bp. ‘Dye-swap’ experiments were performed followed by copy number analysis, as previously described [<xref ref-type="bibr" rid="pone.0153757.ref042">42</xref>].</p>
</sec>
<sec id="sec006">
<title>Polymerase chain reaction (PCR) and mutation analysis</title>
<p>Primer sequences and PCR conditions used for amplification and sequencing of the <italic>FOXC1</italic>, <italic>PITX2</italic>, <italic>PHF21A</italic> and <italic>ARHGAP6</italic> genes are provided in <xref ref-type="supplementary-material" rid="pone.0153757.s004">S2 Table</xref>. PCR reactions were performed in 12μl volumes containing 1μl of 1-in-20 diluted, whole-genome amplified DNA (Genomiphi, GE Healthcare), 6μl of 2 X ReddyMix PCR Mastermix (Abgene), 833 nM of each oligonucleotide primer and 2.4μl of 5 X GC-mix (where appropriate). PCR conditions generally consisted of an initial denaturation at 95°C for 5 minutes, followed by 32 cycles of 94°C for 60 seconds, primer annealing for 60 seconds, and 72°C for 60 seconds, and a final cycle of 72°C for 10 minutes. The products were visualized using agarose gel electrophoresis to ensure adequate yield and proper sizing of each exon fragment. Sequencing of PCR products was performed in both directions as described elsewhere [<xref ref-type="bibr" rid="pone.0153757.ref043">43</xref>]. Sequence traces were analyzed using Mutation Surveyor sequence analysis software version 3.30.</p>
</sec>
<sec id="sec007">
<title>Fluorescence <italic>in situ</italic> hybridization (FISH)</title>
<p>Metaphase spreads for FISH were prepared from patient lymphocytes as described elsewhere [<xref ref-type="bibr" rid="pone.0153757.ref044">44</xref>]. BAC clones were selected from the Ensembl database (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/">http://www.ensembl.org</ext-link>) or the UCSC Human Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu</ext-link>) and ordered from the BACPAC resources centre (Children’s Hospital Oakland Institute). For the initial mapping of the clones, DNA was isolated using a rapid alkaline lysis miniprep method (Qiagen mini/midi plasmid kit). Probes were labeled with biotin-16-dUTP or digoxigenin-11-dUTP (Roche) by nick translation. Probe labelling, DNA hybridization and antibody detection were carried out as described previously [<xref ref-type="bibr" rid="pone.0153757.ref045">45</xref>]. Following hybridization, slides were mounted with a drop of Vectorshield antifadent containing DAPI (Sigma). Antibody detection was carried out by fluorescent microscopy using a Zeiss Axioscop microscope. Images were collected using a cooled CCD (charged coupled device) camera and analyzed using SmartCapture software (Digital Scientific).</p>
</sec>
</sec>
<sec id="sec008" sec-type="results">
<title>Results</title>
<sec id="sec009">
<title>Patient cohort</title>
<p>Our study cohort consisted of 42 unrelated individuals (14 male, 28 female) with iris developmental anomalies (<xref ref-type="table" rid="pone.0153757.t001">Table 1</xref>, <xref ref-type="supplementary-material" rid="pone.0153757.s003">S1 Table</xref>). Eleven of these individuals (2 male, 9 female) had been referred to us with a diagnosis of Gillespie syndrome including individual 1371 who had been previously reported with an apparently balanced reciprocal translocation: t(X;11)(p22.32;p12) [<xref ref-type="bibr" rid="pone.0153757.ref022">22</xref>]. Each proband had been scored negative for intragenic <italic>PAX6</italic> mutations by SSCP, DHPLC and/or direct sequencing in our lab.</p>
<table-wrap id="pone.0153757.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153757.t001</object-id>
<label>Table 1</label>
<caption>
<title>Details of the clinical diagnoses and genetic pathology identified in individuals in this study.</title>
</caption>
<alternatives>
<graphic id="pone.0153757.t001g" xlink:href="pone.0153757.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Individual ID</th>
<th align="left" colspan="1" rowspan="1">DECIPHER ID</th>
<th align="left" colspan="1" rowspan="1">Clinical feature</th>
<th align="left" colspan="1" rowspan="1">Genetic pathology</th>
<th align="left" colspan="1" rowspan="1">Genomic coordinates (hg18)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1851 (control)</td>
<td align="left" colspan="1" rowspan="1">323119</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> deletion (previously identified by FISH)</td>
<td align="left" colspan="1" rowspan="1">chr11:21,254,000–32,564,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2193</td>
<td align="left" colspan="1" rowspan="1">323118</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> whole-gene deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,199,000–31,849,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">377</td>
<td align="left" colspan="1" rowspan="1">323104</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> whole-gene deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,394,000–31,914,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1510</td>
<td align="left" colspan="1" rowspan="1">323113</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> whole-gene deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,779,000–31,933,000)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1977</td>
<td align="left" colspan="1" rowspan="1">323116</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> whole-gene deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,698,271–31,794,414</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1514</td>
<td align="left" colspan="1" rowspan="1">323114</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> telomeric deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:30,874,642–31,654,833</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">753</td>
<td align="left" colspan="1" rowspan="1">323108</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> telomeric deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:30,967,000–31,704,000)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">555</td>
<td align="left" colspan="1" rowspan="1">323106</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> telomeric deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,108,579–31,649,842)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2014</td>
<td align="left" colspan="1" rowspan="1">323117</td>
<td align="left" colspan="1" rowspan="1">Gillespie syndrome</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> telomeric deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,234,395–31,751,815</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">659</td>
<td align="left" colspan="1" rowspan="1">323107</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PAX6</italic> telomeric deletion</td>
<td align="left" colspan="1" rowspan="1">chr11:31,379,000–31,708,000)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1449</td>
<td align="left" colspan="1" rowspan="1">323112</td>
<td align="left" colspan="1" rowspan="1">Gillespie syndrome</td>
<td align="left" colspan="1" rowspan="1"><italic>FOXC1</italic> whole-gene deletion</td>
<td align="left" colspan="1" rowspan="1">chr6:1,543,591–1,675,085</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1246</td>
<td align="left" colspan="1" rowspan="1">323110</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>FOXC1</italic> whole-gene deletion</td>
<td align="left" colspan="1" rowspan="1">chr6:1,543,591–1,675,085</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1839</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>FOXC1</italic> c.235C&gt;A p.(Pro79Thr) <italic>de novo</italic></td>
<td align="left" colspan="1" rowspan="1">Not applicable</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1634</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>FOXC1</italic> c.302T&gt;C p.(Leu101Pro) <italic>de novo</italic></td>
<td align="left" colspan="1" rowspan="1">Not applicable</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1194</td>
<td align="left" colspan="1" rowspan="1">323109</td>
<td align="left" colspan="1" rowspan="1">Aniridia</td>
<td align="left" colspan="1" rowspan="1"><italic>PITX2</italic> telomeric deletion</td>
<td align="left" colspan="1" rowspan="1">chr4:111,994,000–115,504,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1371</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">Gillespie syndrome</td>
<td align="left" colspan="1" rowspan="1">Translocation t(X;11)(p22.32;p12)</td>
<td align="left" colspan="1" rowspan="1">See <xref ref-type="fig" rid="pone.0153757.g005">Fig 5</xref></td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec010">
<title>DNA copy number analysis of the <italic>PAX6</italic> locus</title>
<p>To identify causative segmental aneuploidy, two array-based comparative genomic hybridization (aCGH) approaches were used: a 135k whole-genome array and a custom-designed targeted array covering a contiguous 3 Mb genomic region (chr11:30,262,916–33,296,085; hg18) encompassing <italic>PAX6</italic>. This identified four individuals with heterozygous deletions, all encompassing <italic>PAX6</italic> and ranging in size from 96 kb to 650 kb: individual 2193 (chr11:31,199,000–31,849,000; hg18), individual 377 (chr11:31,394,000–31,914,000; hg18), individual 1510 (chr11:31,779,000–31,933,000; hg18) and individual 1977 (chr11:31,698,271–31,794,414; hg18) (<xref ref-type="table" rid="pone.0153757.t001">Table 1</xref>, <xref ref-type="fig" rid="pone.0153757.g001">Fig 1</xref>, <xref ref-type="supplementary-material" rid="pone.0153757.s001">S1 Fig</xref>). Five individuals had deletions with breakpoints immediately telomeric to <italic>PAX6</italic>: individual 1514 (chr11:30,874,642–31,654,833; hg18), individual 753 (chr11:30,967,000–31,704,000; hg18), individual 555 (chr11:31,108,579–31,649–842; hg18), individual 2014 (chr11:31,234,395–31,751,815; hg18) and individual 659 (chr11:31,379,000–31,708,000; hg18) (<xref ref-type="table" rid="pone.0153757.t001">Table 1</xref>, <xref ref-type="fig" rid="pone.0153757.g002">Fig 2</xref>, <xref ref-type="supplementary-material" rid="pone.0153757.s002">S2 Fig</xref>). Combining these with published data, we suggested a 243.9 kb critical region for <italic>PAX6</italic> transcriptional activation between chr11:31,379,000 (hg18) and chr11:31,622,916 (hg18) (<xref ref-type="fig" rid="pone.0153757.g002">Fig 2</xref>).</p>
<fig id="pone.0153757.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153757.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Identification of <italic>PAX6</italic> whole-gene deletions.</title>
<p>Genome-wide array CGH analysis identified a 650 kb deletion in individual 2193 (chr11:31,199,000–31,849,000), a 520 kb deletion in individual 377 (chr11:31,394,000–31,914,000), a 154 kb deletion in individual 1510 (chr11:31,779,000–31,933,000) and a 96 kb deletion in individual 1977 (chr11:31,698,271–31,794,414), all involving <italic>PAX6</italic>. Red bars show the position of the deletions. Genes transcribed on the forward strand are in blue and those transcribed on the reverse strand are in green, also indicated by arrows. Genomic coordinates are based on the Human Genome Assembly hg18.</p>
</caption>
<graphic xlink:href="pone.0153757.g001"></graphic>
</fig>
<fig id="pone.0153757.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153757.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Identification of regulatory deletions telomeric to <italic>PAX6</italic>.</title>
<p>Regulatory deletions telomeric to <italic>PAX6</italic> were identified in individual 1514 (chr11:30,874,642–31,654,833), individual 753 (chr11:30,967,000–31,704,000), individual 555 (chr11:31,108,579–31,649–842), individual 2014 (chr11:31,234,395–31,751,815) and individual 659 (chr11:31,379,000–31,708,000). The schematic diagram shows how the ‘critical region’ (delimited by grey dotted lines) required for <italic>PAX6</italic> transcriptional activation was delineated by combining our data with published deletions with known coordinates [<xref ref-type="bibr" rid="pone.0153757.ref055">55</xref>,<xref ref-type="bibr" rid="pone.0153757.ref067">67</xref>,<xref ref-type="bibr" rid="pone.0153757.ref068">68</xref>]. <italic>PAX6</italic> regulatory deletions from the present study are shown by red blocks. Genes transcribed on the forward strand are in blue and those transcribed on the reverse strand are in green, also indicated by arrows. Genomic coordinates are based on the Human Genome Assembly hg18.</p>
</caption>
<graphic xlink:href="pone.0153757.g002"></graphic>
</fig>
</sec>
<sec id="sec011">
<title>Mutation analysis of the <italic>FOXC1</italic> locus</title>
<p>An apparently identical 131 kb deletion (chr6:1,543,591–1,675,085; hg18) encompassing <italic>FOXC1</italic> was identified as a <italic>de novo</italic> occurrence in two unrelated individuals 1449 and 1246 (<xref ref-type="table" rid="pone.0153757.t001">Table 1</xref>, <xref ref-type="fig" rid="pone.0153757.g003">Fig 3</xref>). Each of these deletions had been confirmed in an independent UK laboratory using an alternative method. Furthermore, the two individuals were shown to be distinct based on their aCGH profile of genome-wide copy number variants (data not shown). We then screened <italic>FOXC1</italic> in our cohort by direct sequencing. Two individuals were found to carry missense mutations in the <italic>FOXC1</italic> fork-head domain (<xref ref-type="table" rid="pone.0153757.t001">Table 1</xref>, <xref ref-type="fig" rid="pone.0153757.g003">Fig 3</xref>). Individual 1839 had a C&gt;A transversion in codon 79 (c.235C&gt;A, p.(Pro79Thr)) and individual 1634 had a novel T&gt;C transition in codon 101 (c.302T&gt;C, p.(Leu101Pro)). In both individuals, the mutations were absent from the unaffected parents and had most likely occurred <italic>de novo</italic> (<xref ref-type="fig" rid="pone.0153757.g003">Fig 3</xref>). The amino acid substitution p.(Pro79Thr) has been reported previously in a family with classical Axenfeld-Rieger syndrome and the mutant protein has impaired nuclear localization and transactivation activity [<xref ref-type="bibr" rid="pone.0153757.ref046">46</xref>]. The novel p.(Leu101Pro) mutation is predicted to disrupt the second alpha helix of the fork-head domain.</p>
<fig id="pone.0153757.g003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153757.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Mutation analysis of the <italic>FOXC1</italic> locus.</title>
<p><bold>(A)</bold> Genome-wide array CGH identified two deletions encompassing the <italic>FOXC1</italic> gene in individuals 1449 (chr6:1,543,591–1,675,085) and 1246 (chr6:1,543,591–1,675,085). <bold>(B)</bold> Direct sequencing of the <italic>FOXC1</italic> coding region identified a heterozygous substitution in individual 1839 (c.235C&gt;A, p.(Pro79Thr)) and another in individual 1634 (c.302T&gt;C, p.(Leu101Pro)). <italic>FOXC1</italic> mutation screening in unaffected parents of both patients showed that the mutations had occurred <italic>de novo</italic>. The locations of both mutations within the fork-head domain of the FOXC1 protein are indicated by vertical arrows. Genes transcribed on the forward strand are in blue and those transcribed on the reverse strand are in green, also indicated by arrows. Genomic coordinates are based on the Human Genome Assembly hg18. The genomic sequence identifier for <italic>FOXC1</italic> is NG_009368.</p>
</caption>
<graphic xlink:href="pone.0153757.g003"></graphic>
</fig>
</sec>
<sec id="sec012">
<title>Mutation analysis of the <italic>PITX2</italic> locus</title>
<p>Array CGH identified a 3.5 Mb deletion of 4q25-q26 (chr4:111,994,000–115,504,000; hg18) in individual 1194 (<xref ref-type="table" rid="pone.0153757.t001">Table 1</xref>, <xref ref-type="fig" rid="pone.0153757.g004">Fig 4</xref>). This deletion encompasses 8 genes (<xref ref-type="fig" rid="pone.0153757.g004">Fig 4</xref>). The centromeric breakpoint is located in a gene desert 230 kb telomeric (5ʹ) to <italic>PITX2</italic> encompassing several conserved <italic>PITX2</italic> enhancer elements [<xref ref-type="bibr" rid="pone.0153757.ref047">47</xref>]. Subsequent screening of the <italic>PITX2</italic> coding sequence in our cohort revealed no plausible disease-causing mutations.</p>
<fig id="pone.0153757.g004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153757.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Identification of a potential <italic>PITX2</italic> regulatory deletion.</title>
<p>Genome-wide array CGH identified a deletion of approximately 3.5 Mb in individual 1194 (chr4:111,994,000–115,504,000) (red bar). The deletion is located telomeric to the <italic>PITX2</italic> gene on chromosome 4. The positions of conserved elements (CE) in the deleted region, as identified by Volkmann et al., 2011 [<xref ref-type="bibr" rid="pone.0153757.ref047">47</xref>] are marked by orange ellipses. Genes transcribed on the forward strand are in blue and those transcribed on the reverse strand are in green, also indicated by arrows. Genomic coordinates are shown on the x-axis and are based on the Human Genome Assembly hg18.</p>
</caption>
<graphic xlink:href="pone.0153757.g004"></graphic>
</fig>
</sec>
<sec id="sec013">
<title>Breakpoint mapping of a translocation in an individual with Gillespie syndrome</title>
<p>FISH was used to map the previously reported t(X;11)(p22.32;p12) reciprocal translocation in individual 1371 (<xref ref-type="fig" rid="pone.0153757.g005">Fig 5</xref>). The breakpoint on chromosome 11 (now 11p11.2) lay within a single BAC, RP11-618K13 [<xref ref-type="bibr" rid="pone.0153757.ref048">48</xref>], which contains 5 known genes, <italic>CRY2</italic>, <italic>MAPK8IP1</italic>, <italic>PEX16</italic>, <italic>GYLTL1B</italic>, and <italic>PHF21A</italic> (also known as <italic>BHC80</italic>), located approximately 14.1 Mb centromeric to <italic>PAX6</italic>. The breakpoint was shown to lie within <italic>PHF21A</italic> using probes generated by long-range PCR from exons 14–16 (telomeric to the breakpoint) and exons 4–11 (centromeric to the breakpoint) (data not shown). The X chromosome breakpoint (now Xp22.2) was spanned by two overlapping BACs (RP11-121K9 and RP11-311A17) [<xref ref-type="bibr" rid="pone.0153757.ref048">48</xref>] covering two genes, <italic>AMELX</italic> and <italic>ARHGAP6</italic> (<xref ref-type="fig" rid="pone.0153757.g005">Fig 5</xref>). Using a probe generated by long-range PCR, the breakpoint was localized within a large intron of <italic>ARHGAP6</italic> (<xref ref-type="fig" rid="pone.0153757.g005">Fig 5</xref>).</p>
<fig id="pone.0153757.g005" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153757.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Fluorescence <italic>in situ</italic> hybridization (FISH) was used to map the translocation breakpoints on chromosomes 11 and X in individual 1371.</title>
<p>The breakpoint-spanning BAC clones RP11-311A17 (Xp22.2; left panel) and RP11-618K13 (11p11.2; right panel) show signals on both the derivative 11 and derivative X. The schematic diagram demonstrates the position of the BAC clones and the genes involved, to scale. Breakpoint-spanning BACs are coloured in red, with the approximate position of the breakpoints shown by orange bars, as determined by long-range PCR. Genes transcribed on the forward strand are in blue and those transcribed on the reverse strand are in green. Genomic coordinates are shown on the x-axis and are based on the Human Genome Assembly hg18.</p>
</caption>
<graphic xlink:href="pone.0153757.g005"></graphic>
</fig>
</sec>
<sec id="sec014">
<title>Mutation analysis of breakpoint genes in Gillespie syndrome patients</title>
<p>Direct sequencing of the coding exons and essential splice sites of <italic>PHF21A</italic> and <italic>ARHGAP6</italic> revealed only polymorphic variants in the 10 individuals with Gillespie syndrome who lacked a detectable chromosomal abnormality at these loci. <italic>HCCS</italic> is located approximately 150 kb telomeric to the X chromosome breakpoint in individual 1371. Mutations in this gene have been associated with microphthalmia with linear skin defects (MIM 309801). Direct sequencing of <italic>HCCS</italic> revealed no mutations in the 10 non-translocation Gillespie cases.</p>
</sec>
</sec>
<sec id="sec015" sec-type="conclusions">
<title>Discussion</title>
<p>A high proportion of cases of aniridia is caused by loss-of-function mutations in a single gene, <italic>PAX6</italic>. Here we studied individuals with aniridia and Gillespie syndrome, who had previously scored negative for intragenic <italic>PAX6</italic> mutations, using a variety of molecular approaches to identify causative mutations. The rationale for the analysis was that we had a strong prior expectation that this cohort would be heavily enriched for causative structural chromosomal anomalies involving <italic>PAX6</italic> itself, but also for possible new disease loci and/or novel mutational mechanisms. In the event, we identified deletions that result in <italic>PAX6</italic> haploinsufficiency in only 9/42 probands: four encompassing <italic>PAX6</italic> itself and five removing 3ʹ (telomeric) <italic>cis</italic>-regulatory elements that are essential for PAX6 function. A wealth of evidence exists from animal models [<xref ref-type="bibr" rid="pone.0153757.ref049">49</xref>–<xref ref-type="bibr" rid="pone.0153757.ref052">52</xref>] and human translocation breakpoint mapping [<xref ref-type="bibr" rid="pone.0153757.ref053">53</xref>,<xref ref-type="bibr" rid="pone.0153757.ref054">54</xref>] showing that genomic elements located in a region ~120kb 3ʹ to the transcription unit are essential for the transcriptional activation of <italic>PAX6</italic>. For chromosomal deletions the most convincing evidence is from somatic cell hybrid analysis of two deletions that were shown to abolish <italic>PAX6</italic> transcription [<xref ref-type="bibr" rid="pone.0153757.ref055">55</xref>]. The deletions studied in this somatic cell hybrid analysis both overlap with the 3ʹ deletions identified here (<xref ref-type="fig" rid="pone.0153757.g002">Fig 2</xref>) and by combining our data with the published data we suggest a new 244 kb ‘critical region’ which contains essential <italic>cis</italic>-regulatory elements (<xref ref-type="fig" rid="pone.0153757.g002">Fig 2</xref>). The patient cohort in the present study is part of a larger cohort of iris developmental anomalies patients in which one individual with aniridia was recently found to have a plausibly causative <italic>de novo</italic> single nucleotide variant (SNV) in a conserved non-coding element within the ‘critical region’ [<xref ref-type="bibr" rid="pone.0153757.ref056">56</xref>]. While it is possible that similar mutations may exist in other <italic>cis</italic>-regulatory elements, it is significant that most of the individuals in the present study were included in the cohort of 60 individuals screened for <italic>PAX6</italic> regulatory mutations by Bhatia <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0153757.ref056">56</xref>] and no further mutations were identified in the regions analyzed.</p>
<p>Four individuals had deletions or intragenic mutations which are likely to result in <italic>FOXC1</italic> haploinsufficiency. One individual had a large deletion upstream of <italic>PITX2</italic> that plausibly impairs developmental expression of this gene by removing known enhancer elements. Deletions of <italic>FOXC1</italic> were previously shown to account for a considerable proportion of individuals with anterior segment dysgenesis, who also presented with extraocular features such as hearing defects and mental retardation [<xref ref-type="bibr" rid="pone.0153757.ref057">57</xref>]. <italic>FOXC1</italic> and <italic>PITX2</italic> encode transcriptional regulators that physically interact with each other and are co-expressed in a number of tissues during development including the periocular mesenchyme [<xref ref-type="bibr" rid="pone.0153757.ref058">58</xref>]. Mutations in these genes have most commonly been associated with Axenfeld-Rieger syndrome [<xref ref-type="bibr" rid="pone.0153757.ref059">59</xref>], but aniridia has been reported for both [<xref ref-type="bibr" rid="pone.0153757.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0153757.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0153757.ref060">60</xref>]. Of note, 3 of the 4 individuals reported here with <italic>FOXC1</italic> haploinsufficiency, and the individual with the <italic>PITX2 cis</italic>-regulatory mutation have congenital glaucoma associated with their aniridia phenotype. However, none of the nine individuals with <italic>PAX6</italic> mutations had congenital glaucoma. Digenic inheritance of <italic>FOXC1</italic> and <italic>PITX2</italic> mutations was reported in a severely affected individual in a family with several affected members presenting with variable ocular phenotypes associated with Axenfeld-Rieger syndrome [<xref ref-type="bibr" rid="pone.0153757.ref013">13</xref>]. The presence of both FOXC1 and PITX2 mutations impaired the transactivation activity of these proteins <italic>in vitro</italic> significantly more than when only one mutation was present. The cellular and developmental interactions between PAX6, FOXC1 and PITX2, and physical co-binding at regulatory elements in the developing iris are as yet poorly understood. This is presumably due to the difficulty in obtaining sufficient tissue, although the available human genetic data suggest that this would be an informative area of study.</p>
<p>We assessed the occurrence of particular descriptive phenotype terms (partial/variant aniridia, corneal anomalies, cataracts, glaucoma, microphthalmia/coloboma and extraocular features) in cases with and without a molecular diagnosis (<xref ref-type="supplementary-material" rid="pone.0153757.s005">S3 Table</xref>). The results showed an over-representation of individuals with partial/variant aniridia in whom no genetic defect was detected (approximately 60%) when compared to those with the same descriptive term but no genetic diagnosis (approximately 26%). This finding can be explained by the presence of 8/11 Gillespie syndrome patients in whom a genetic mutation is yet to be identified. The glaucoma feature appeared to be present in 26% of individuals with a molecular diagnosis (particularly in <italic>FOXC1</italic> and <italic>PITX2</italic> mutation-positive patients) compared to 7% of those without a diagnosis.</p>
<p>Finally, we report a more complex mutation associated with the breakpoints of a balanced X:autosome translocation in a single individual. On chromosome 11 the breakpoint disrupts <italic>PHF21A</italic>, which encodes a plant-homeodomain zinc finger protein and is highly expressed in brain tissue including the cerebellum [<xref ref-type="bibr" rid="pone.0153757.ref061">61</xref>]. The PHF12A protein is a component of the BRAF-histone deacetylase co-repressor complex, which mediates transcriptional repression of neuron-specific genes in non-neuronal cells [<xref ref-type="bibr" rid="pone.0153757.ref062">62</xref>]. Multiple translocation breakpoints disrupting <italic>PHF21A</italic> have been reported as causing intellectual disability [<xref ref-type="bibr" rid="pone.0153757.ref063">63</xref>] and alteration of <italic>PHF12A</italic> expression in the cerebellum might contribute to the ataxia seen in this case but we were unable to find any evidence that <italic>PHF21A</italic> could be causing the iris malformation. The breakpoint on the X chromosome disrupts <italic>ARHGAP6</italic>, which is highly expressed in kidney, heart, skeletal muscle, retina and fetal brain. <italic>ARHGAP6</italic> encodes a guanine nucleotide exchange factor that activates Rho-GTPase to regulate signaling interactions within the actin cytoskeleton [<xref ref-type="bibr" rid="pone.0153757.ref064">64</xref>,<xref ref-type="bibr" rid="pone.0153757.ref065">65</xref>]. However, there is no human genetics evidence as yet that mutations in this gene are associated with any developmental disorder. We were also unable to find mutations in the neighbouring gene, <italic>HCCS</italic>, in the other Gillespie syndrome cases in our cohort. <italic>HCCS</italic> has been associated with syndromic microphthalmia [<xref ref-type="bibr" rid="pone.0153757.ref066">66</xref>]. It seems reasonable to consider individual 1371 as having a composite phenotype with <italic>PHF21A</italic>-disrupting breakpoint exacerbating the neurodevelopmental problems but the Gillespie syndrome being, as yet, unexplained.</p>
<p>Perhaps the most significant finding in this study is that we were unable to identify mutations in 27/42 individuals with aniridia and no detectable intragenic mutations in <italic>PAX6</italic>. Although there could be unidentified mechanisms for disrupting PAX6 function, our results also suggests that there may be as yet undiscovered genetic loci responsible for a considerable proportion of aniridia. Whole genome sequence analysis would be an attractive technique for the identification of novel causative mutations in the <italic>PAX6</italic> region, and others involving new loci in <italic>PAX6</italic>-negative individuals with syndromic or isolated aniridia. The high frequency of <italic>cis</italic>-regulatory mutations that we have identified in this cohort highlight the importance of surveying the whole genome. This study has also confirmed that the majority of cases with Gillespie syndrome are not associated with detectable mutations at the <italic>PAX6</italic> locus.</p>
</sec>
<sec id="sec016" sec-type="supplementary-material">
<title>Supporting Information</title>
<supplementary-material content-type="local-data" id="pone.0153757.s001">
<label>S1 Fig</label>
<caption>
<title>Array CGH data for <italic>PAX6</italic> deletion individuals.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0153757.s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0153757.s002">
<label>S2 Fig</label>
<caption>
<title>Array CGH data for <italic>PAX6</italic> telomeric deletion individuals.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0153757.s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0153757.s003">
<label>S1 Table</label>
<caption>
<title>Details of the clinical diagnoses of all the patients used in this study, including the genetic pathology (where applicable).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0153757.s003.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0153757.s004">
<label>S2 Table</label>
<caption>
<title>Primer sequences and PCR conditions used for amplification and sequencing of the <italic>PAX6</italic>, <italic>FOXC1</italic>, <italic>PITX2</italic>, <italic>PHF21A</italic> and <italic>ARHGAP6</italic></title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0153757.s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0153757.s005">
<label>S3 Table</label>
<caption>
<title>Occurrence of particular descriptive phenotypes in cases with and without a molecular diagnosis.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0153757.s005.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0153757.ref001">
<label>1</label>
<mixed-citation publication-type="journal"><name><surname>Boonstra</surname><given-names>N</given-names></name>, <name><surname>Limburg</surname><given-names>H</given-names></name>, <name><surname>Tijmes</surname><given-names>N</given-names></name>, <name><surname>van Genderen</surname><given-names>M</given-names></name>, <name><surname>Schuil</surname><given-names>J</given-names></name>, <name><surname>van Nispen</surname><given-names>R</given-names></name> (<year>2012</year>) <article-title>Changes in causes of low vision between 1988 and 2009 in a Dutch population of children</article-title>. <source/>Acta Ophthalmol
<volume>90</volume>: <fpage>277</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1111/j.1755-3768.2011.02205.x</pub-id>
<pub-id pub-id-type="pmid">21812942</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Gronskov</surname><given-names>K</given-names></name>, <name><surname>Rosenberg</surname><given-names>T</given-names></name>, <name><surname>Sand</surname><given-names>A</given-names></name>, <name><surname>Brondum-Nielsen</surname><given-names>K</given-names></name> (<year>1999</year>) <article-title>Mutational analysis of PAX6: 16 novel mutations including 5 missense mutations with a mild aniridia phenotype</article-title>. <source/>Eur J Hum Genet
<volume>7</volume>: <fpage>274</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="pmid">10234503</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Dubey</surname><given-names>SK</given-names></name>, <name><surname>Mahalaxmi</surname><given-names>N</given-names></name>, <name><surname>Vijayalakshmi</surname><given-names>P</given-names></name>, <name><surname>Sundaresan</surname><given-names>P</given-names></name> (<year>2015</year>) <article-title>Mutational analysis and genotype-phenotype correlations in southern Indian patients with sporadic and familial aniridia</article-title>. <source/>Mol Vis
<volume>21</volume>: <fpage>88</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="pmid">25678763</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref004">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Hever</surname><given-names>AM</given-names></name>, <name><surname>Williamson</surname><given-names>KA</given-names></name>, <name><surname>van Heyningen</surname><given-names>V</given-names></name> (<year>2006</year>) <article-title>Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2</article-title>. <source/>Clin Genet
<volume>69</volume>: <fpage>459</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="pmid">16712695</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Hingorani</surname><given-names>M</given-names></name>, <name><surname>Hanson</surname><given-names>I</given-names></name>, <name><surname>van Heyningen</surname><given-names>V</given-names></name> (<year>2012</year>) <article-title>Aniridia</article-title>. <source/>Eur J Hum Genet
<volume>20</volume>: <fpage>1011</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2012.100</pub-id>
<pub-id pub-id-type="pmid">22692063</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Reis</surname><given-names>LM</given-names></name>, <name><surname>Semina</surname><given-names>EV</given-names></name> (<year>2011</year>) <article-title>Genetics of anterior segment dysgenesis disorders</article-title>. <source/>Curr Opin Ophthalmol
<volume>22</volume>: <fpage>314</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1097/ICU.0b013e328349412b</pub-id>
<pub-id pub-id-type="pmid">21730847</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Azuma</surname><given-names>N</given-names></name>, <name><surname>Yamaguchi</surname><given-names>Y</given-names></name>, <name><surname>Handa</surname><given-names>H</given-names></name>, <name><surname>Tadokoro</surname><given-names>K</given-names></name>, <name><surname>Asaka</surname><given-names>A</given-names></name>, <name><surname>Kawase</surname><given-names>E</given-names></name>
<etal>et al</etal> (<year>2003</year>) <article-title>Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations</article-title>. <source/>Am J Hum Genet
<volume>72</volume>: <fpage>1565</fpage>–<lpage>1570</lpage>. <pub-id pub-id-type="pmid">12721955</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Ito</surname><given-names>YA</given-names></name>, <name><surname>Footz</surname><given-names>TK</given-names></name>, <name><surname>Berry</surname><given-names>FB</given-names></name>, <name><surname>Mirzayans</surname><given-names>F</given-names></name>, <name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Khan</surname><given-names>AO</given-names></name>
<etal>et al</etal> (<year>2009</year>) <article-title>Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia</article-title>. <source/>Invest Ophthalmol Vis Sci
<volume>50</volume>: <fpage>3573</fpage>–<lpage>3579</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.08-3032</pub-id>
<pub-id pub-id-type="pmid">19279310</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Sadagopan</surname><given-names>KA</given-names></name>, <name><surname>Liu</surname><given-names>GT</given-names></name>, <name><surname>Capasso</surname><given-names>JE</given-names></name>, <name><surname>Wuthisiri</surname><given-names>W</given-names></name>, <name><surname>Keep</surname><given-names>RB</given-names></name>, <name><surname>Levin</surname><given-names>AV</given-names></name> (<year>2015</year>) <article-title>Anirdia-like phenotype caused by 6p25 dosage aberrations</article-title>. <source/>Am J Med Genet A
<volume>167A</volume>: <fpage>524</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36890</pub-id>
<pub-id pub-id-type="pmid">25691405</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref010">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AO</given-names></name>, <name><surname>Aldahmesh</surname><given-names>MA</given-names></name>, <name><surname>Alkuraya</surname><given-names>FS</given-names></name> (<year>2011</year>) <article-title>Genetic and genomic analysis of classic aniridia in Saudi Arabia</article-title>. <source/>Mol Vis
<volume>17</volume>: <fpage>708</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="pmid">21423868</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AO</given-names></name>, <name><surname>Aldahmesh</surname><given-names>MA</given-names></name>, <name><surname>Al-Amri</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Heterozygous FOXC1 mutation (M161K) associated with congenital glaucoma and aniridia in an infant and a milder phenotype in her mother</article-title>. <source/>Ophthalmic Genet
<volume>29</volume>: <fpage>67</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1080/13816810801908152</pub-id>
<pub-id pub-id-type="pmid">18484311</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>TC</given-names></name>, <name><surname>Summers</surname><given-names>CG</given-names></name>, <name><surname>Schimmenti</surname><given-names>LA</given-names></name>, <name><surname>Grajewski</surname><given-names>AL</given-names></name> (<year>2012</year>) <article-title>Axenfeld-Rieger syndrome: new perspectives</article-title>. <source/>Br J Ophthalmol
<volume>96</volume>: <fpage>318</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1136/bjophthalmol-2011-300801</pub-id>
<pub-id pub-id-type="pmid">22199394</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Kelberman</surname><given-names>D</given-names></name>, <name><surname>Islam</surname><given-names>L</given-names></name>, <name><surname>Holder</surname><given-names>SE</given-names></name>, <name><surname>Jacques</surname><given-names>TS</given-names></name>, <name><surname>Calvas</surname><given-names>P</given-names></name>, <name><surname>Hennekam</surname><given-names>RC</given-names></name>
<etal>et al</etal> (<year>2011</year>) <article-title>Digenic inheritance of mutations in FOXC1 and PITX2: correlating transcription factor function and Axenfeld-Rieger disease severity</article-title>. <source/>Hum Mutat
<volume>32</volume>: <fpage>1144</fpage>–<lpage>1152</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21550</pub-id>
<pub-id pub-id-type="pmid">21837767</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Law</surname><given-names>SK</given-names></name>, <name><surname>Sami</surname><given-names>M</given-names></name>, <name><surname>Piri</surname><given-names>N</given-names></name>, <name><surname>Coleman</surname><given-names>AL</given-names></name>, <name><surname>Caprioli</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>Asymmetric phenotype of Axenfeld-Rieger anomaly and aniridia associated with a novel PITX2 mutation</article-title>. <source/>Mol Vis
<volume>17</volume>: <fpage>1231</fpage>–<lpage>1238</lpage>. <pub-id pub-id-type="pmid">21617748</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Fischbach</surname><given-names>BV</given-names></name>, <name><surname>Trout</surname><given-names>KL</given-names></name>, <name><surname>Lewis</surname><given-names>J</given-names></name>, <name><surname>Luis</surname><given-names>CA</given-names></name>, <name><surname>Sika</surname><given-names>M</given-names></name> (<year>2005</year>) <article-title>WAGR syndrome: a clinical review of 54 cases</article-title>. <source/>Pediatrics
<volume>116</volume>: <fpage>984</fpage>–<lpage>988</lpage>. <pub-id pub-id-type="pmid">16199712</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Gillespie</surname><given-names>FD</given-names></name> (<year>1965</year>) <article-title>Aniridia, Cerebellar Ataxia, and Oligophrenia in Siblings</article-title>. <source/>Arch Ophthalmol
<volume>73</volume>: <fpage>338</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="pmid">14246186</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Agarwal</surname><given-names>PK</given-names></name>, <name><surname>Awan</surname><given-names>MA</given-names></name>, <name><surname>Dutton</surname><given-names>GN</given-names></name>, <name><surname>Strang</surname><given-names>N</given-names></name> (<year>2009</year>) <article-title>Gillespie syndrome with impaired accommodation</article-title>. <source/>J Pediatr Ophthalmol Strabismus
<volume>46</volume>: <fpage>60</fpage>
<pub-id pub-id-type="pmid">19213284</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Agarwal</surname><given-names>PK</given-names></name>, <name><surname>Awan</surname><given-names>MA</given-names></name>, <name><surname>Strang</surname><given-names>N</given-names></name>, <name><surname>Dutton</surname><given-names>GN</given-names></name> (<year>2009</year>) <article-title>Gillespie syndrome with impaired accommodation</article-title>. <source/>J Pediatr Ophthalmol Strabismus
<volume>46</volume>: <fpage>317</fpage>
<pub-id pub-id-type="doi">10.3928/01913913-20090903-12</pub-id>
<pub-id pub-id-type="pmid">19791732</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Boughamoura</surname><given-names>L</given-names></name>, <name><surname>Yacoub</surname><given-names>M</given-names></name>, <name><surname>Abroug</surname><given-names>M</given-names></name>, <name><surname>Chabchoub</surname><given-names>I</given-names></name>, <name><surname>Bouguezzi</surname><given-names>R</given-names></name>, <name><surname>Charfeddine</surname><given-names>L</given-names></name>
<etal>et al</etal> (<year>2006</year>) [<article-title>Gillespie syndrome: 2 familial cases</article-title>]. <source/>Arch Pediatr
<volume>13</volume>: <fpage>1323</fpage>–<lpage>1325</lpage>. <pub-id pub-id-type="pmid">16919425</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Defreyn</surname><given-names>A</given-names></name>, <name><surname>Maugery</surname><given-names>J</given-names></name>, <name><surname>Chabrier</surname><given-names>S</given-names></name>, <name><surname>Coullet</surname><given-names>J</given-names></name> (<year>2007</year>) [<article-title>Gillespie syndrome: an uncommon presentation of congenital aniridia</article-title>]. <source/>J Fr Ophtalmol
<volume>30</volume>: <fpage>e1</fpage>
<pub-id pub-id-type="pmid">17287663</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Dell'acqua Cassao</surname><given-names>B</given-names></name>, <name><surname>de Rezende</surname><given-names>DT</given-names></name>, <name><surname>Silva</surname><given-names>LC</given-names></name>, <name><surname>Herbella</surname><given-names>FA</given-names></name> (<year>2013</year>) <article-title>Esophageal dysmotility in gillespie syndrome</article-title>. <source/>J Neurogastroenterol Motil
<volume>19</volume>: <fpage>538</fpage>–<lpage>539</lpage>. <pub-id pub-id-type="doi">10.5056/jnm.2013.19.4.538</pub-id>
<pub-id pub-id-type="pmid">24199016</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref022">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Dollfus</surname><given-names>H</given-names></name>, <name><surname>Joanny-Flinois</surname><given-names>O</given-names></name>, <name><surname>Doco-Fenzy</surname><given-names>M</given-names></name>, <name><surname>Veyre</surname><given-names>L</given-names></name>, <name><surname>Joanny-Flinois</surname><given-names>L</given-names></name>, <name><surname>Khoury</surname><given-names>M</given-names></name>
<etal>et al</etal> (<year>1998</year>) <article-title>Gillespie syndrome phenotype with a t(X;11)(p22.32;p12) de novo translocation</article-title>. <source/>Am J Ophthalmol
<volume>125</volume>: <fpage>397</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="pmid">9512164</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Donald</surname><given-names>KA</given-names></name>, <name><surname>Grotte</surname><given-names>R</given-names></name>, <name><surname>Crutchley</surname><given-names>AC</given-names></name>, <name><surname>Wilmshurst</surname><given-names>JM</given-names></name> (<year>2006</year>) <article-title>Gillespie syndrome: two further cases</article-title>. <source/>J Child Neurol
<volume>21</volume>: <fpage>337</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="pmid">16900933</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Eden</surname><given-names>U</given-names></name>, <name><surname>Beijar</surname><given-names>C</given-names></name>, <name><surname>Riise</surname><given-names>R</given-names></name>, <name><surname>Tornqvist</surname><given-names>K</given-names></name> (<year>2008</year>) <article-title>Aniridia among children and teenagers in Sweden and Norway</article-title>. <source/>Acta Ophthalmol
<volume>86</volume>: <fpage>730</fpage>–<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1111/j.1755-3768.2008.01310.x</pub-id>
<pub-id pub-id-type="pmid">18494744</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Francois</surname><given-names>J</given-names></name>, <name><surname>Lentini</surname><given-names>F</given-names></name> (<year>1984</year>) [<article-title>Gillespie syndrome (incomplete aniridia, cerebellar ataxia and oligophrenia)</article-title>]. <source/>Klin Monbl Augenheilkd
<volume>184</volume>: <fpage>313</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="pmid">6727263</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref026">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Glaser</surname><given-names>T</given-names></name>, <name><surname>Ton</surname><given-names>CC</given-names></name>, <name><surname>Mueller</surname><given-names>R</given-names></name>, <name><surname>Petzl-Erler</surname><given-names>ML</given-names></name>, <name><surname>Oliver</surname><given-names>C</given-names></name>, <name><surname>Nevin</surname><given-names>NC</given-names></name>
<etal>et al</etal> (<year>1994</year>) <article-title>Absence of PAX6 gene mutations in Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation)</article-title>. <source/>Genomics
<volume>19</volume>: <fpage>145</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="pmid">8188215</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref027">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Kieslich</surname><given-names>M</given-names></name>, <name><surname>Vanselow</surname><given-names>K</given-names></name>, <name><surname>Wildhardt</surname><given-names>G</given-names></name>, <name><surname>Gebhardt</surname><given-names>B</given-names></name>, <name><surname>Weis</surname><given-names>R</given-names></name>, <name><surname>Bohles</surname><given-names>H</given-names></name> (<year>2001</year>) [<article-title>Present limitations of molecular biological diagnostics in Gillespie syndrome</article-title>]. <source/>Klin Padiatr
<volume>213</volume>: <fpage>47</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="pmid">11305191</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Luquetti</surname><given-names>DV</given-names></name>, <name><surname>Oliveira-Sobrinho</surname><given-names>RP</given-names></name>, <name><surname>Gil-da-Silva-Lopes</surname><given-names>VL</given-names></name> (<year>2007</year>) <article-title>Gillespie syndrome: additional findings and parental consanguinity</article-title>. <source/>Ophthalmic Genet
<volume>28</volume>: <fpage>89</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="pmid">17558851</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Marien</surname><given-names>P</given-names></name>, <name><surname>Brouns</surname><given-names>R</given-names></name>, <name><surname>Engelborghs</surname><given-names>S</given-names></name>, <name><surname>Wackenier</surname><given-names>P</given-names></name>, <name><surname>Verhoeven</surname><given-names>J</given-names></name>, <name><surname>Ceulemans</surname><given-names>B</given-names></name>
<etal>et al</etal> (<year>2008</year>) <article-title>Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome</article-title>. <source/>Cortex
<volume>44</volume>: <fpage>54</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.cortex.2005.12.001</pub-id>
<pub-id pub-id-type="pmid">18387531</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Nelson</surname><given-names>J</given-names></name>, <name><surname>Flaherty</surname><given-names>M</given-names></name>, <name><surname>Grattan-Smith</surname><given-names>P</given-names></name> (<year>1997</year>) <article-title>Gillespie syndrome: a report of two further cases</article-title>. <source/>Am J Med Genet
<volume>71</volume>: <fpage>134</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="pmid">9217210</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref031">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>Nevin</surname><given-names>NC</given-names></name>, <name><surname>Lim</surname><given-names>JH</given-names></name> (<year>1990</year>) <article-title>Syndrome of partial aniridia, cerebellar ataxia, and mental retardation—Gillespie syndrome</article-title>. <source/>Am J Med Genet
<volume>35</volume>: <fpage>468</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="pmid">2333873</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Quarrell</surname><given-names>O</given-names></name> (<year>1993</year>) <article-title>Gillespie syndrome reported as bilateral congenital mydriasis</article-title>. <source/>Br J Ophthalmol
<volume>77</volume>: <fpage>827</fpage>–<lpage>828</lpage>.</mixed-citation>
</ref>
<ref id="pone.0153757.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Ticho</surname><given-names>BH</given-names></name>, <name><surname>Hilchie-Schmidt</surname><given-names>C</given-names></name>, <name><surname>Egel</surname><given-names>RT</given-names></name>, <name><surname>Traboulsi</surname><given-names>EI</given-names></name>, <name><surname>Howarth</surname><given-names>RJ</given-names></name>, <name><surname>Robinson</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>Ocular findings in Gillespie-like syndrome: association with a new PAX6 mutation</article-title>. <source/>Ophthalmic Genet
<volume>27</volume>: <fpage>145</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="pmid">17148041</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Verhulst</surname><given-names>S</given-names></name>, <name><surname>Smet</surname><given-names>H</given-names></name>, <name><surname>Ceulemans</surname><given-names>B</given-names></name>, <name><surname>Geerts</surname><given-names>Y</given-names></name>, <name><surname>Tassignon</surname><given-names>MJ</given-names></name> (<year>1993</year>) <article-title>Gillespie syndrome, partial aniridia, cerebellar ataxia and mental retardation in mother and daughter</article-title>. <source/>Bull Soc Belge Ophtalmol
<volume>250</volume>: <fpage>37</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="pmid">7952360</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Wittig</surname><given-names>EO</given-names></name>, <name><surname>Moreira</surname><given-names>CA</given-names></name>, <name><surname>Freire-Maia</surname><given-names>N</given-names></name>, <name><surname>Vianna-Morgante</surname><given-names>AM</given-names></name> (<year>1988</year>) <article-title>Partial aniridia, cerebellar ataxia, and mental deficiency (Gillespie syndrome) in two brothers</article-title>. <source/>Am J Med Genet
<volume>30</volume>: <fpage>703</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="pmid">3189393</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Crawfurd</surname><given-names>MD</given-names></name>, <name><surname>Harcourt</surname><given-names>RB</given-names></name>, <name><surname>Shaw</surname><given-names>PA</given-names></name> (<year>1979</year>) <article-title>Non-progressive cerebellar ataxia, aplasia of pupillary zone of iris, and mental subnormality (Gillespie's syndrome) affecting 3 members of a non-consanguineous family in 2 generations</article-title>. <source/>J Med Genet
<volume>16</volume>: <fpage>373</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="pmid">513084</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Dilling-Ostrowska</surname><given-names>E</given-names></name>, <name><surname>Zuchowicz</surname><given-names>M</given-names></name> (<year>1973</year>) [<article-title>Case of Gillespie's syndrome</article-title>]. <source/>Neurol Neurochir Pol
<volume>7</volume>: <fpage>97</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="pmid">4690708</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Francois</surname><given-names>J</given-names></name>, <name><surname>Lentini</surname><given-names>F</given-names></name>, <name><surname>de Rouck</surname><given-names>F</given-names></name> (<year>1984</year>) <article-title>Gillespie's syndrome (incomplete aniridia, cerebellar ataxia and oligophrenia)</article-title>. <source/>Ophthalmic Paediatr Genet
<volume>4</volume>: <fpage>29</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="pmid">6544390</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Graziano</surname><given-names>C</given-names></name>, <name><surname>D'Elia</surname><given-names>AV</given-names></name>, <name><surname>Mazzanti</surname><given-names>L</given-names></name>, <name><surname>Moscano</surname><given-names>F</given-names></name>, <name><surname>Guidelli</surname><given-names>Guidi S</given-names></name>, <name><surname>Scarano</surname><given-names>E</given-names></name>
<etal>et al</etal> (<year>2007</year>) <article-title>A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation</article-title>. <source/>Am J Med Genet A
<volume>143A</volume>: <fpage>1802</fpage>–<lpage>1805</lpage>. <pub-id pub-id-type="pmid">17595013</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Hanson</surname><given-names>I</given-names></name>, <name><surname>Churchill</surname><given-names>A</given-names></name>, <name><surname>Love</surname><given-names>J</given-names></name>, <name><surname>Axton</surname><given-names>R</given-names></name>, <name><surname>Moore</surname><given-names>T</given-names></name>, <name><surname>Clarke</surname><given-names>M</given-names></name>
<etal>et al</etal> (<year>1999</year>) <article-title>Missense mutations in the most ancient residues of the PAX6 paired domain underlie a spectrum of human congenital eye malformations</article-title>. <source/>Hum Mol Genet
<volume>8</volume>: <fpage>165</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="pmid">9931324</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref041">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Gerth-Kahlert</surname><given-names>C</given-names></name>, <name><surname>Williamson</surname><given-names>K</given-names></name>, <name><surname>Ansari</surname><given-names>M</given-names></name>, <name><surname>Rainger</surname><given-names>JK</given-names></name>, <name><surname>Hingst</surname><given-names>V</given-names></name>, <name><surname>Zimmermann</surname><given-names>T</given-names></name>
<etal>et al</etal> (<year>2013</year>) <article-title>Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center</article-title>. <source/>Mol Genet Genomic Med
<volume>1</volume>: <fpage>15</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.2</pub-id>
<pub-id pub-id-type="pmid">24498598</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Ansari</surname><given-names>M</given-names></name>, <name><surname>Rainger</surname><given-names>JK</given-names></name>, <name><surname>Murray</surname><given-names>JE</given-names></name>, <name><surname>Hanson</surname><given-names>I</given-names></name>, <name><surname>Firth</surname><given-names>HV</given-names></name>, <name><surname>Mehendale</surname><given-names>F</given-names></name>
<etal>et al</etal> (<year>2014</year>) <article-title>A syndromic form of Pierre Robin sequence is caused by 5q23 deletions encompassing FBN2 and PHAX</article-title>. <source/>Eur J Med Genet
<volume>57</volume>: <fpage>587</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2014.08.007</pub-id>
<pub-id pub-id-type="pmid">25195018</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Aijaz</surname><given-names>S</given-names></name>, <name><surname>Clark</surname><given-names>BJ</given-names></name>, <name><surname>Williamson</surname><given-names>K</given-names></name>, <name><surname>van Heyningen</surname><given-names>V</given-names></name>, <name><surname>Morrison</surname><given-names>D</given-names></name>, <name><surname>FitzPatrick</surname><given-names>D</given-names></name>
<etal>et al</etal> (<year>2004</year>) <article-title>Absence of SIX6 mutations in microphthalmia, anophthalmia, and coloboma</article-title>. <source/>Invest Ophthalmol Vis Sci
<volume>45</volume>: <fpage>3871</fpage>–<lpage>3876</lpage>. <pub-id pub-id-type="pmid">15505031</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Weier</surname><given-names>HU</given-names></name>, <name><surname>Zitzelsberger</surname><given-names>HF</given-names></name>, <name><surname>Gray</surname><given-names>JW</given-names></name> (<year>1991</year>) <article-title>Non-isotopical labeling of murine heterochromatin in situ by hybridization with in vitro-synthesized biotinylated gamma (major) satellite DNA</article-title>. <source/>BioTechniques
<volume>10</volume>: <page-range>498–502, 504–5</page-range>
<pub-id pub-id-type="pmid">1867859</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref045">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Chong</surname><given-names>SS</given-names></name>, <name><surname>Pack</surname><given-names>SD</given-names></name>, <name><surname>Roschke</surname><given-names>AV</given-names></name>, <name><surname>Tanigami</surname><given-names>A</given-names></name>, <name><surname>Carrozzo</surname><given-names>R</given-names></name>, <name><surname>Smith</surname><given-names>AC</given-names></name>
<etal>et al</etal> (<year>1997</year>) <article-title>A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3</article-title>. <source/>Hum Mol Genet
<volume>6</volume>: <fpage>147</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="pmid">9063734</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref046">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>Saleem</surname><given-names>RA</given-names></name>, <name><surname>Banerjee-Basu</surname><given-names>S</given-names></name>, <name><surname>Berry</surname><given-names>FB</given-names></name>, <name><surname>Baxevanis</surname><given-names>AD</given-names></name>, <name><surname>Walter</surname><given-names>MA</given-names></name> (<year>2003</year>) <article-title>Structural and functional analyses of disease-causing missense mutations in the forkhead domain of FOXC1</article-title>. <source/>Hum Mol Genet
<volume>12</volume>: <fpage>2993</fpage>–<lpage>3005</lpage>. <pub-id pub-id-type="pmid">14506133</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref047">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Volkmann</surname><given-names>BA</given-names></name>, <name><surname>Zinkevich</surname><given-names>NS</given-names></name>, <name><surname>Mustonen</surname><given-names>A</given-names></name>, <name><surname>Schilter</surname><given-names>KF</given-names></name>, <name><surname>Bosenko</surname><given-names>DV</given-names></name>, <name><surname>Reis</surname><given-names>LM</given-names></name>
<etal>et al</etal> (<year>2011</year>) <article-title>Potential novel mechanism for Axenfeld-Rieger syndrome: deletion of a distant region containing regulatory elements of PITX2</article-title>. <source/>Invest Ophthalmol Vis Sci
<volume>52</volume>: <fpage>1450</fpage>–<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.10-6060</pub-id>
<pub-id pub-id-type="pmid">20881290</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref048">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>Fantes</surname><given-names>JA</given-names></name>, <name><surname>Boland</surname><given-names>E</given-names></name>, <name><surname>Ramsay</surname><given-names>J</given-names></name>, <name><surname>Donnai</surname><given-names>D</given-names></name>, <name><surname>Splitt</surname><given-names>M</given-names></name>, <name><surname>Goodship</surname><given-names>JA</given-names></name>
<etal>et al</etal> (<year>2008</year>) <article-title>FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality</article-title>. <source/>Am J Hum Genet
<volume>82</volume>: <fpage>916</fpage>–<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.02.007</pub-id>
<pub-id pub-id-type="pmid">18374296</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref049">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Bhatia</surname><given-names>S</given-names></name>, <name><surname>Gordon</surname><given-names>CT</given-names></name>, <name><surname>Foster</surname><given-names>RG</given-names></name>, <name><surname>Melin</surname><given-names>L</given-names></name>, <name><surname>Abadie</surname><given-names>V</given-names></name>, <name><surname>Baujat</surname><given-names>G</given-names></name>
<etal>et al</etal> (<year>2015</year>) <article-title>Functional assessment of disease-associated regulatory variants in vivo using a versatile dual colour transgenesis strategy in zebrafish</article-title>. <source/>PLoS Genet
<volume>11</volume>: <fpage>e1005193</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005193</pub-id>
<pub-id pub-id-type="pmid">26030420</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref050">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Kleinjan</surname><given-names>DA</given-names></name>, <name><surname>Bancewicz</surname><given-names>RM</given-names></name>, <name><surname>Gautier</surname><given-names>P</given-names></name>, <name><surname>Dahm</surname><given-names>R</given-names></name>, <name><surname>Schonthaler</surname><given-names>HB</given-names></name>, <name><surname>Damante</surname><given-names>G</given-names></name>
<etal>et al</etal> (<year>2008</year>) <article-title>Subfunctionalization of duplicated zebrafish pax6 genes by cis-regulatory divergence</article-title>. <source/>PLoS Genet
<volume>4</volume>: <fpage>e29</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.0040029</pub-id>
<pub-id pub-id-type="pmid">18282108</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref051">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Ravi</surname><given-names>V</given-names></name>, <name><surname>Bhatia</surname><given-names>S</given-names></name>, <name><surname>Gautier</surname><given-names>P</given-names></name>, <name><surname>Loosli</surname><given-names>F</given-names></name>, <name><surname>Tay</surname><given-names>BH</given-names></name>, <name><surname>Tay</surname><given-names>A</given-names></name>
<etal>et al</etal> (<year>2013</year>) <article-title>Sequencing of Pax6 loci from the elephant shark reveals a family of Pax6 genes in vertebrate genomes, forged by ancient duplications and divergences</article-title>. <source/>PLoS Genet
<volume>9</volume>: <fpage>e1003177</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003177</pub-id>
<pub-id pub-id-type="pmid">23359656</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref052">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Rowan</surname><given-names>S</given-names></name>, <name><surname>Siggers</surname><given-names>T</given-names></name>, <name><surname>Lachke</surname><given-names>SA</given-names></name>, <name><surname>Yue</surname><given-names>Y</given-names></name>, <name><surname>Bulyk</surname><given-names>ML</given-names></name>, <name><surname>Maas</surname><given-names>RL</given-names></name> (<year>2010</year>) <article-title>Precise temporal control of the eye regulatory gene Pax6 via enhancer-binding site affinity</article-title>. <source/>Genes Dev
<volume>24</volume>: <fpage>980</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1890410</pub-id>
<pub-id pub-id-type="pmid">20413611</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref053">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Fantes</surname><given-names>J</given-names></name>, <name><surname>Redeker</surname><given-names>B</given-names></name>, <name><surname>Breen</surname><given-names>M</given-names></name>, <name><surname>Boyle</surname><given-names>S</given-names></name>, <name><surname>Brown</surname><given-names>J</given-names></name>, <name><surname>Fletcher</surname><given-names>J</given-names></name>
<etal>et al</etal> (<year>1995</year>) <article-title>Aniridia-associated cytogenetic rearrangements suggest that a position effect may cause the mutant phenotype</article-title>. <source/>Hum Mol Genet
<volume>4</volume>: <fpage>415</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="pmid">7795596</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref054">
<label>54</label>
<mixed-citation publication-type="journal"><name><surname>Kleinjan</surname><given-names>DA</given-names></name>, <name><surname>Seawright</surname><given-names>A</given-names></name>, <name><surname>Schedl</surname><given-names>A</given-names></name>, <name><surname>Quinlan</surname><given-names>RA</given-names></name>, <name><surname>Danes</surname><given-names>S</given-names></name>, <name><surname>van Heyningen</surname></name> (<year>2001</year>) <article-title>Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6</article-title>. <source/>Hum Mol Genet
<volume>10</volume>: <fpage>2049</fpage>–<lpage>2059</lpage>. <pub-id pub-id-type="pmid">11590122</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref055">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Lauderdale</surname><given-names>JD</given-names></name>, <name><surname>Wilensky</surname><given-names>JS</given-names></name>, <name><surname>Oliver</surname><given-names>ER</given-names></name>, <name><surname>Walton</surname><given-names>DS</given-names></name>, <name><surname>Glaser</surname><given-names>T</given-names></name> (<year>2000</year>) <article-title>3' deletions cause aniridia by preventing PAX6 gene expression</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>97</volume>: <fpage>13755</fpage>–<lpage>13759</lpage>. <pub-id pub-id-type="pmid">11087823</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref056">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Bhatia</surname><given-names>S</given-names></name>, <name><surname>Bengani</surname><given-names>H</given-names></name>, <name><surname>Fish</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>A</given-names></name>, <name><surname>Divizia</surname><given-names>MT</given-names></name>, <name><surname>de Marco</surname><given-names>R</given-names></name>
<etal>et al</etal> (<year>2013</year>) <article-title>Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia</article-title>. <source/>Am J Hum Genet
<volume>93</volume>: <fpage>1126</fpage>–<lpage>1134</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.10.028</pub-id>
<pub-id pub-id-type="pmid">24290376</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref057">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>D'haene</surname><given-names>B</given-names></name>, <name><surname>Meire</surname><given-names>F</given-names></name>, <name><surname>Claerhout</surname><given-names>I</given-names></name>, <name><surname>Kroes</surname><given-names>HY</given-names></name>, <name><surname>Plomp</surname><given-names>A</given-names></name>, <name><surname>Arens</surname><given-names>YH</given-names></name>
<etal>et al</etal> (<year>2011</year>) <article-title>Expanding the spectrum of FOXC1 and PITX2 mutations and copy number changes in patients with anterior segment malformations</article-title>. <source/>Invest Ophthalmol Vis Sci
<volume>52</volume>: <fpage>324</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.10-5309</pub-id>
<pub-id pub-id-type="pmid">20881294</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref058">
<label>58</label>
<mixed-citation publication-type="journal"><name><surname>Acharya</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>L</given-names></name>, <name><surname>Fleisch</surname><given-names>VC</given-names></name>, <name><surname>Allison</surname><given-names>WT</given-names></name>, <name><surname>Walter</surname><given-names>MA</given-names></name> (<year>2011</year>) <article-title>A complex regulatory network of transcription factors critical for ocular development and disease</article-title>. <source/>Hum Mol Genet
<volume>20</volume>: <fpage>1610</fpage>–<lpage>1624</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr038</pub-id>
<pub-id pub-id-type="pmid">21282189</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref059">
<label>59</label>
<mixed-citation publication-type="journal"><name><surname>Tumer</surname><given-names>Z</given-names></name>, <name><surname>Bach-Holm</surname><given-names>D</given-names></name> (<year>2009</year>) <article-title>Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations</article-title>. <source/>Eur J Hum Genet
<volume>17</volume>: <fpage>1527</fpage>–<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2009.93</pub-id>
<pub-id pub-id-type="pmid">19513095</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref060">
<label>60</label>
<mixed-citation publication-type="journal"><name><surname>Perveen</surname><given-names>R</given-names></name>, <name><surname>Lloyd</surname><given-names>IC</given-names></name>, <name><surname>Clayton-Smith</surname><given-names>J</given-names></name>, <name><surname>Churchill</surname><given-names>A</given-names></name>, <name><surname>van Heyningen</surname><given-names>V</given-names></name>, <name><surname>Hanson</surname><given-names>I</given-names></name>
<etal>et al</etal> (<year>2000</year>) <article-title>Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations</article-title>. <source/>Invest Ophthalmol Vis Sci
<volume>41</volume>: <fpage>2456</fpage>–<lpage>2460</lpage>. <pub-id pub-id-type="pmid">10937553</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref061">
<label>61</label>
<mixed-citation publication-type="journal"><name><surname>Iwase</surname><given-names>S</given-names></name>, <name><surname>Shono</surname><given-names>N</given-names></name>, <name><surname>Honda</surname><given-names>A</given-names></name>, <name><surname>Nakanishi</surname><given-names>T</given-names></name>, <name><surname>Kashiwabara</surname><given-names>S</given-names></name>, <name><surname>Takahashi</surname><given-names>S</given-names></name>
<etal>et al</etal> (<year>2006</year>) <article-title>A component of BRAF-HDAC complex, BHC80, is required for neonatal survival in mice</article-title>. <source/>FEBS Lett
<volume>580</volume>: <fpage>3129</fpage>–<lpage>3135</lpage>. <pub-id pub-id-type="pmid">16684532</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref062">
<label>62</label>
<mixed-citation publication-type="journal"><name><surname>Klajn</surname><given-names>A</given-names></name>, <name><surname>Ferrai</surname><given-names>C</given-names></name>, <name><surname>Stucchi</surname><given-names>L</given-names></name>, <name><surname>Prada</surname><given-names>I</given-names></name>, <name><surname>Podini</surname><given-names>P</given-names></name>, <name><surname>Baba</surname><given-names>T</given-names></name>
<etal>et al</etal> (<year>2009</year>) <article-title>The rest repression of the neurosecretory phenotype is negatively modulated by BHC80, a protein of the BRAF/HDAC complex</article-title>. <source/>J Neurosci
<volume>29</volume>: <fpage>6296</fpage>–<lpage>6307</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5943-08.2009</pub-id>
<pub-id pub-id-type="pmid">19439607</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref063">
<label>63</label>
<mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>HG</given-names></name>, <name><surname>Kim</surname><given-names>HT</given-names></name>, <name><surname>Leach</surname><given-names>NT</given-names></name>, <name><surname>Lan</surname><given-names>F</given-names></name>, <name><surname>Ullmann</surname><given-names>R</given-names></name>, <name><surname>Silahtaroglu</surname><given-names>A</given-names></name>
<etal>et al</etal> (<year>2012</year>) <article-title>Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies</article-title>. <source/>Am J Hum Genet
<volume>91</volume>: <fpage>56</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.005</pub-id>
<pub-id pub-id-type="pmid">22770980</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref064">
<label>64</label>
<mixed-citation publication-type="journal"><name><surname>Prakash</surname><given-names>SK</given-names></name>, <name><surname>Paylor</surname><given-names>R</given-names></name>, <name><surname>Jenna</surname><given-names>S</given-names></name>, <name><surname>Lamarche-Vane</surname><given-names>N</given-names></name>, <name><surname>Armstrong</surname><given-names>DL</given-names></name>, <name><surname>Xu</surname><given-names>B</given-names></name>
<etal>et al</etal> (<year>2000</year>) <article-title>Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA</article-title>. <source/>Hum Mol Genet
<volume>9</volume>: <fpage>477</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="pmid">10699171</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref065">
<label>65</label>
<mixed-citation publication-type="journal"><name><surname>Schaefer</surname><given-names>L</given-names></name>, <name><surname>Prakash</surname><given-names>S</given-names></name>, <name><surname>Zoghbi</surname><given-names>HY</given-names></name> (<year>1997</year>) <article-title>Cloning and characterization of a novel rho-type GTPase-activating protein gene (ARHGAP6) from the critical region for microphthalmia with linear skin defects</article-title>. <source/>Genomics
<volume>46</volume>: <fpage>268</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="pmid">9417914</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref066">
<label>66</label>
<mixed-citation publication-type="journal"><name><surname>Wimplinger</surname><given-names>I</given-names></name>, <name><surname>Morleo</surname><given-names>M</given-names></name>, <name><surname>Rosenberger</surname><given-names>G</given-names></name>, <name><surname>Iaconis</surname><given-names>D</given-names></name>, <name><surname>Orth</surname><given-names>U</given-names></name>, <name><surname>Meinecke</surname><given-names>P</given-names></name>
<etal>et al</etal> (<year>2006</year>) <article-title>Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome</article-title>. <source/>Am J Hum Genet
<volume>79</volume>: <fpage>878</fpage>–<lpage>889</lpage>. <pub-id pub-id-type="pmid">17033964</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref067">
<label>67</label>
<mixed-citation publication-type="journal"><name><surname>Bayrakli</surname><given-names>F</given-names></name>, <name><surname>Guney</surname><given-names>I</given-names></name>, <name><surname>Bayri</surname><given-names>Y</given-names></name>, <name><surname>Ercan-Sencicek</surname><given-names>AG</given-names></name>, <name><surname>Ceyhan</surname><given-names>D</given-names></name>, <name><surname>Cankaya</surname><given-names>T</given-names></name>
<etal>et al</etal> (<year>2009</year>) <article-title>A novel heterozygous deletion within the 3' region of the PAX6 gene causing isolated aniridia in a large family group</article-title>. <source/>J Clin Neurosci
<volume>16</volume>: <fpage>1610</fpage>–<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2009.03.022</pub-id>
<pub-id pub-id-type="pmid">19793656</pub-id></mixed-citation>
</ref>
<ref id="pone.0153757.ref068">
<label>68</label>
<mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>LK</given-names></name>, <name><surname>Meyer</surname><given-names>KJ</given-names></name>, <name><surname>Rudd</surname><given-names>DS</given-names></name>, <name><surname>Librant</surname><given-names>AL</given-names></name>, <name><surname>Epping</surname><given-names>EA</given-names></name>, <name><surname>Sheffield</surname><given-names>VC</given-names></name>
<etal>et al</etal> (<year>2008</year>) <article-title>Pax6 3' deletion results in aniridia, autism and mental retardation</article-title>. <source/>Hum Genet
<volume>123</volume>: <fpage>371</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-008-0484-x</pub-id>
<pub-id pub-id-type="pmid">18322702</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>